Showing results (2901-2910 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|December 2, 2010
Relative bioavailability of generic and branded acetylcysteine effervescent tablets: A single-dose, open-label, randomized-sequence, two-period crossover study in fasting healthy Chinese male volunteersYan-Mei Liu, Yun Liu, Chuan Lu, et al.
Clinical Therapeutics|October 27, 2010
A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trialsSihai Zhao, Enqi Liu, Ping Chen, et al.
Clinical Therapeutics|October 27, 2010
Comparison of effects of two different formulations of clopidogrel bisulfate tablets on platelet aggregation and bleeding time in healthy Korean volunteers: A single-dose, randomized, open-label, 1-week, two-period, phase IV crossover studyChi Young Shim, Sungha Park, Jae Woo Song, et al.
Clinical Therapeutics|October 27, 2010
The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover studyKun-Yan Li, Jian-Ping Liang, Bing-Qiang Hu, et al.
Clinical Therapeutics|March 15, 2013
Geographic variation of chronic opioid use in fibromyalgiaJacob T Painter, Leslie J Crofford, Jeffery Talbert
Clinical Therapeutics|January 19, 2013
Cost-effectiveness of continuation maintenance pemetrexed after cisplatin and pemetrexed chemotherapy for advanced nonsquamous non-small-cell lung cancer: estimates from the perspective of the Chinese health care systemXiaohui Zeng, Liubao Peng, Jianhe Li, et al.
Clinical Therapeutics|January 19, 2013
The effects of ethanol on the pharmacokinetics, pharmacodynamics, safety, and tolerability of ezogabine (retigabine)Christopher S Crean, Debra J Tompson
Clinical Therapeutics|January 19, 2013
Childhood obesity: a review of increased risk for physical and psychological comorbiditiesElizabeth R Pulgarón
Clinical Therapeutics|January 19, 2013
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesityJames R Taylor, Eric Dietrich, Jason G Powell
Clinical Therapeutics|January 22, 2013
Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trialAndrew Lewin, Henry Punzi, Xiaohui Luo, et al.
Pageof 680